Medical devices can be ultra reliable, lucrative business, but there are plenty of ways for companies to blow it, too.
News & Analysis: Intersect ENT
On a down day for the market, these stocks struggled more than most.
Shares fall hard after the company reports rough first-quarter results and announces a leadership transition.
XENT earnings call for the period ending March 31, 2019.
XENT earnings call for the period ending December 31, 2018.
XENT earnings call for the period ending September 30, 2018.
Shares tumbled after the company reported mixed second-quarter results and gave disappointing guidance. Here's what investors need to know.
Here's why these healthcare specialists believe it's a great time to buy a few shares of these three healthcare winners.
First-quarter financial results are fueling investor optimism.
Third-quarter results are overcoming headwinds related to J.P. Morgan's downgrade of Intersect ENT's stock yesterday.